Can definitive chemoradiation offer a cure along with cosmesis in locally advanced IVA carcinoma buccal mucosa? a case report
DOI:
https://doi.org/10.18203/2349-3259.ijct20232201Keywords:
Definitive chemoradiation, Ca buccal mucosa, PaclitaxelAbstract
Surgery is the mainstay of the treatment in ca buccal mucosa. It is extensive in nature and may require efficient reconstruction for good cosmetic outcome. Adjuvant radiation or chemo-radiation may be needed in advanced cancers. Definitive chemoradiation or palliative radiation are reserved for inoperable patients. We present a case report of advanced carcinoma of oral cavity in the left buccal mucosa along with involvement of retromolar trigone along with bone involvement in left sided mandible who opted out for undergoing definitive surgery. She was treated with definitive chemoradiation with 2.4 Gy per day /0.4 Gy in morning, 2 Gy in evening five days a week along with paclitaxel on Sunday. Patient reported after seven years disease free with excellent cosmetic outcome. Definitive surgery along with adjuvant radiation or chemoradiation is the standard of care in advanced cancers of buccal mucosa. However, in inoperable patients or the patients refusing surgery definitive chemoradiation with altered fractionation schedules may still offer a chance of cure and good cosmesis.
Metrics
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.
Lin CS, Jen YM, Cheng MF, Lin YS, Su WF, Hwang JM, et al. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck. 2006;28(2):150-7.
Adriaansens CMEM, Noorlag R, Visscher WP, de Bree R, Breimer GE, van Es RJJ. A closer look at the resection margins of buccal mucosa cancer: Their influence on local recurrence free survival. Head Neck. 2023;45(4):983-92.
Kim IH, Myoung H. Squamous cell carcinoma of the buccal mucosa involving the masticator space: a case report. J Korean Assoc Oral Maxillofac Surg. 2017;43(3):191-6.
Bera A, Banerjee C, Dutta S, Biswas L. Concurrent chemoradiation with paclitaxel in locally advanced head and neck cancer: A feasibility study from tertiary cancer care center. Int J Med Sci Public Health. 2019;8(11):991-5.
Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59(4):928-42.
Bachar G, Goldstein DP, Barker E, Lea J, O'Sullivan B, Brown DH, et al. Squamous cell carcinoma of the buccal mucosa: outcomes of treatment in the modern era. Laryngoscope. 2012;122(7):1552-7.
Foster CC, Melotek JM, Brisson RJ, Seiwert TY, Cohen EEW, Stenson KM, et al. Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. Oral Oncol. 2018;80:16-22.
Downloads
Published
Issue
Section
